Price Alert

Puma Biotechnology Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

5.73

0.41 (7.71%)

At close: Aug 15, 2025, 3:59 PM

5.79

1.05%

After-hours: Aug 15, 2025, 07:19 PM EDT

Puma Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	238.06M	232.71M	230.47M	243.57M	219.14M	226.63M	235.64M	229.16M	230.15M	235.09M	228.06M	217.76M	206.9M	200.76M	253.2M	250.4M	254.91M	272.11M
Cost of Revenue	65.88M	64.23M	64.4M	74.81M	58.99M	60.19M	62.68M	55.16M	54.37M	57.43M	55.06M	50.16M	47.94M	44.99M	63.7M	62.7M	62.37M	59.81M
Gross Profit	172.19M	168.48M	166.06M	168.76M	160.15M	166.44M	172.96M	174M	175.78M	177.66M	173M	167.6M	158.96M	155.77M	189.49M	187.69M	192.54M	212.29M
Operating Income	46.06M	37.25M	30.97M	32.4M	18.91M	25.98M	32.64M	27.84M	28.93M	36.1M	31.05M	27.85M	9.22M	-19.47M	1.36M	-16.74M	-19.92M	3.84M
Interest Income	4.57M	4.85M	4.72M	4.22M	3.62M	3.04M	2.6M	2.4M	1.93M	1.34M	813K	307K	104K	160K	160K	162K	171K	116K
Pretax Income	42.28M	31.96M	24.1M	24.67M	10.07M	16.53M	22.67M	4.57M	-1.73M	5.38M	469K	10.17M	-34.17M	-48.67M	-28.74M	-48.14M	-34.97M	-26.5M
Net Income	48.45M	38.07M	30.28M	23.24M	8.72M	15.38M	21.59M	3.72M	-2.43M	4.81M	8K	9.83M	-34.48M	-48.96M	-29.03M	-48.25M	-35.04M	-26.54M
Selling & General & Admin	69.54M	76.46M	80.61M	83.77M	89.08M	88.57M	89.31M	94.22M	96.01M	92.12M	90.04M	87.44M	89.56M	108.4M	116.23M	122.53M	126.05M	115.98M
Research & Development	57.03M	55.21M	54.94M	52.64M	51.54M	51.26M	50.38M	51.31M	51.12M	49.73M	52.26M	52.66M	60.24M	66.91M	71.9M	81.9M	86.41M	92.46M
Other Expenses	-446K	-446K	-446K	-48K	625K	711K	669K	469K	-92K	-116K	-24K	276K	283K	281K	273K	273K	330K	347K
Operating Expenses	126.12M	131.23M	135.1M	136.36M	141.25M	140.46M	140.31M	146.16M	147.13M	141.85M	142.29M	140.09M	149.8M	175.31M	188.13M	204.43M	212.46M	208.45M
Interest Expense	9.73M	11.27M	12.45M	13.19M	13.42M	13.38M	13.33M	13.26M	12.86M	12.24M	11.59M	11.01M	11.19M	12M	12.79M	13.69M	14.2M	14.46M
Selling & Marketing Expenses	n/a	-183K	-73K	294K	294K	477K	367K	61K	61K	61K	61K	38K	38K	38K	38K	194K	194K	194K
Cost & Expenses	192M	195.46M	199.5M	211.17M	200.24M	200.65M	203M	201.32M	201.5M	199.28M	197.35M	190.25M	197.74M	220.3M	251.84M	267.14M	274.82M	268.26M
Income Tax Expense	-6.76M	-6.69M	-6.18M	1.43M	1.35M	1.16M	1.08M	847K	701K	571K	461K	361K	331K	312K	313K	113.2K	76.2K	38.2K
Shares Outstanding (Basic)	49.7M	49.6M	49.1M	49.01M	48.29M	48.19M	47.6M	47.52M	46.76M	46.64M	45.81M	45.57M	45.06M	42.21M	40.99M	40.81M	39.28M	40.26M
Shares Outstanding (Diluted)	50.14M	49.91M	49.41M	49.17M	48.29M	48.19M	48.04M	47.82M	47.2M	47.16M	45.81M	45.57M	45.36M	42.21M	41.04M	40.81M	40.48M	40.89M
EPS (Basic)	0.98	0.77	0.61	0.48	0.19	0.33	0.46	0.08	-0.05	0.11	0.00	0.22	-0.86	-1.2	-0.71	-1.19	-0.89	-0.67
EPS (Diluted)	0.98	0.77	0.61	0.48	0.19	0.33	0.45	0.07	-0.05	0.11	0.00	0.22	-0.86	-1.2	-0.72	-1.2	-0.9	-0.69
EBITDA	63.29M	54.66M	48.08M	48.69M	33.56M	39.95M	46.02M	27.89M	21.31M	27.31M	21.07M	30M	-13.95M	-27.09M	14.51M	-2.79M	11.38M	19.36M
EBIT	52.01M	43.23M	36.55M	37.12M	21.99M	27.66M	33.27M	15.81M	9.88M	17.12M	12.05M	21.24M	-22.93M	-36.61M	4.24M	-14.14M	-460K	8.22M
Depreciation & Amortization	11.28M	11.42M	11.52M	11.57M	11.57M	11.54M	11.52M	10.84M	10.19M	9.6M	8.92M	8.98M	9.2M	9.85M	10.6M	11.28M	11.77M	11.07M